University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.

Scientists are deploying this state-of-the-art X-ray crystallography facility to study biological molecules related to the COVID-19 pandemic.

In a new perspective, SLAC and University of Paderborn scientists argue that research at synchrotrons could help improve water-purifying materials in ways that might not otherwise be possible.

Marking the beginning of the LCLS-II era, the first phase of the major upgrade comes online.

A proposed device could expand the reach of X-ray lasers, opening new experimental avenues in biology, chemistry, materials science and physics.

Understanding nature’s process could inform the next generation of artificial photosynthetic systems that produce clean and renewable energy from sunlight and water.

The lab is responding to the coronavirus crisis by imaging disease-related biomolecules, developing standards for reliable coronavirus testing and enabling other essential research.

A better understanding of this phenomenon, which is crucial to many processes that occur in biological systems and materials, could enable researchers to develop light-sensitive proteins for areas such as biological imaging and optogenetics.

What they learned could lead to a better understanding of how antibiotics are broken down in the body, potentially leading to the development of more effective drugs.

A new study uncovers how a critical protein binds to drugs used to treat asthma and other inflammatory diseases.

A better understanding of ‘checkpoint proteins,’ which protect cancer cells against immune system strikes, could lead to the development of more effective drugs.

She is recognized for two decades of innovation and excellence at the Stanford Synchrotron Radiation Lightsource.